在前列腺癌中表观遗传 (去) 调节
Chenxi Xu1,2, Shuai Zhao1,2, Ling Cai3,4
1Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA.
Cancer treatment and research
|December 19, 2023
概括
表观遗传改变驱动前列腺癌 (PCa) 的进展和治疗耐药性. 用抑制剂向这些可逆表观遗传变化为晚期前列腺癌治疗提供了一个有希望的策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 前列腺癌 (PCa) 是一种复杂的疾病,具有遗传和表观遗传改变.
- 雄激素受体 (AR) 信号驱动PCa,雄激素剥夺疗法 (ADT) 是一种标准的治疗方法.
- 对ADT的抵抗不可避免地发展,导致割抵抗性前列腺癌 (CRPC).
研究的目的:
- 审查最近关于PCa表观遗传调节器失调的研究.
- 讨论表观遗传变化在PCa启动,发展和进展中的作用.
- 探索表观遗传抑制剂对高级PCa的治疗潜力.
主要方法:
- 对最近关于前列腺癌表观遗传变化的研究进行文献综述.
- 对表观遗传调节因子在PCa病变发生中的作用的分析.
- 讨论针对晚期前列腺癌的新兴表观遗传疗法.
主要成果:
- 表观遗传修饰,包括DNA甲基化和基因质突变,在PCa中至关重要.
- 表观遗传因素的失调有助于ADT耐药性和CRPC的发展.
- 表观遗传抑制剂显示出作为高级PCa的新型治疗剂的前景.
结论:
- 表观遗传失调是前列腺癌进展和抗性的关键驱动因素.
- 向表观遗传修饰代表了对割抵抗性前列腺癌的有希望的治疗途径.
- 对表观遗传抑制剂的进一步研究可能会导致高级PCa的改善治疗方法.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Regulation of Expression at Multiple Steps
916
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
916
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


